Gilead Sciences Switzerland Sàrl - Eviplera, Filmtabletten | | 62155 | | 01 | | Eviplera | | Filmtabletten | | J05AR08 | | | | 12.03.2013 | | |
| Composition | emtricitabinum 200 mg, rilpivirinum 25 mg ut rilpivirini hydrochloridum, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili fumaras, cellulosum microcristallinum, lactosum monohydricum 269.8 mg, povidonum, amylum pregelificatum, polysorbatum 20, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 7.25 mg, macrogola, triacetinum, E 110 0.02 mg, E 132, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 7.2 mg. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Emtricitabine | 200 mg | | 25 mg | Tenofovir Disoproxil | 245 mg |
| BAG: Principe actif | Concentr. |
---|
Emtricitabine | 200 mg | | 25 mg | Tenofovir Disoproxil | 245 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
| | | | | | | | | | | | | 0.02 mg | color. | | | color. | | | color. | | | color. | Hypromellosum | | Überzug | Lactose Monohydrate | 7.25 mg | | | | | | | | | | | Povidone | | | | | | | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 30 Comprimé(s) | 780.92 | 865.70 | A | LS | Non |
|
|